Evidence map›Paper›PMID 25497302›Full record

ArticleJournal of molecular and cellular cardiology2015

Mitochondrial remodeling in mice with cardiomyocyte-specific lipid overload.

Aly Elezaby, Aaron L Sverdlov, Vivian H Tu, Kanupriya Soni, Ivan Luptak, Fuzhong Qin, Marc Liesa, Orian S Shirihai, Jamie Rimer, Jean E Schaffer and 2 more

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular and cellular cardiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Effects of Lipid Overload on Heart in Metabolic Diseases.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 2021
    Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Role of GTPase-Dependent Mitochondrial Dynamins in Heart Diseases.Frontiers in cardiovascular medicine · 2021
    Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Aly ElezabyBoston University School of Medicine, Whitaker Cardiovascular Institute, Section of Cardiovascular Medicine, Boston, MA 02118, United States.
Aaron L SverdlovBoston University School of Medicine, Whitaker Cardiovascular Institute, Section of Cardiovascular Medicine, Boston, MA 02118, United States.
Vivian H TuBoston University School of Medicine, Whitaker Cardiovascular Institute, Section of Cardiovascular Medicine, Boston, MA 02118, United States.
Kanupriya SoniBoston University School of Medicine, Whitaker Cardiovascular Institute, Section of Cardiovascular Medicine, Boston, MA 02118, United States.
Ivan LuptakBoston University School of Medicine, Whitaker Cardiovascular Institute, Section of Cardiovascular Medicine, Boston, MA 02118, United States.
Fuzhong QinBoston University School of Medicine, Whitaker Cardiovascular Institute, Section of Cardiovascular Medicine, Boston, MA 02118, United States.
Marc LiesaBoston University School of Medicine, Obesity and Nutrition Section, Department of Medicine, Boston, MA 02118, United States.
Orian S ShirihaiBoston University School of Medicine, Obesity and Nutrition Section, Department of Medicine, Boston, MA 02118, United States.
Jamie RimerWashington University School of Medicine, Diabetic Cardiovascular Disease Center, St Louis, MO 63110, United States.
Jean E SchafferWashington University School of Medicine, Diabetic Cardiovascular Disease Center, St Louis, MO 63110, United States.
Wilson S ColucciBoston University School of Medicine, Whitaker Cardiovascular Institute, Section of Cardiovascular Medicine, Boston, MA 02118, United States.
Edward J MillerBoston University School of Medicine, Whitaker Cardiovascular Institute, Section of Cardiovascular Medicine, Boston, MA 02118, United States. Electronic address: ejmiller@bu.edu.
Boston University · USWashington University in St. Louis · US

Funding

WU P&FP30DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI James Alexander Fitzpatrick · 2013 to 2026
$27.1M
Oxidative Stress in Myocardial Remodeling and FailureR01HL064750 · NHLBI · BOSTON MEDICAL CENTER · PI COLUCCI, WILSON S. · 2001 to 2018
$5.0M
Lipid Biomarkers for Diabetic Heart DiseaseP20HL113444 · NHLBI · WASHINGTON UNIVERSITY · PI SCHAFFER, JEAN E. · 2012 to 2016
$4.7M
NHLBI PROTEOMICS INITIATIVEN01HV28178 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · 2007 to 2008
$2.8M
The Role and Regulation of the LKB1-AMPK Axis in Diabetic CardiomyopathyK08HL109158 · NHLBI · YALE UNIVERSITY · PI MILLER, EDWARD JAMES · 2011 to 2015
$644k
NHLBI PROTEOMICS INITIATIVE-N01HV28178N01HV028178 · HV · BOSTON UNIVERSITY MEDICAL CAMPUS · PI COSTELLO, CATHERINE E. · 2002 to 2006
–
NHLBI NIH HHS K08 HL109158NHLBI NIH HHS N01 HV028178NHLBI NIH HHS N01 HV28178NHLBI NIH HHS P20 HL113444NHLBI NIH HHS R01 HL064750NIDDK NIH HHS P30 DK020579
6 · The paper itself

Abstract

backgroundObesity leads to metabolic heart disease (MHD) that is associated with a pathologic increase in myocardial fatty acid (FA) uptake and impairment of mitochondrial function. The mechanism of mitochondrial dysfunction in MHD, which results in oxidant production and decreased energetics, is poorly understood but may be related to excess FAs. Determining the effects of cardiac FA excess on mitochondria can be hindered by the systemic sequelae of obesity. Mice with cardiomyocyte-specific overexpression of the fatty acid transport protein FATP1 have increased cardiomyocyte FA uptake and develop MHD in the absence of systemic lipotoxicity, obesity or diabetes. We utilized this model to assess 1) the effect of cardiomyocyte lipid accumulation on mitochondrial structure and energetic function and 2) the role of lipid-driven transcriptional regulation, signaling, toxic metabolite accumulation, and mitochondrial oxidative stress in lipid-induced MHD.

methodsCardiac lipid species, lipid-dependent signaling, and mitochondrial structure/function were examined from FATP1 mice. Cardiac structure and function were assessed in mice overexpressing both FATP1 and mitochondrial-targeted catalase.

resultsFATP1 hearts exhibited a net increase (+12%) in diacylglycerol, with increases in several very long-chain diacylglycerol species (+160-212%, p<0.001) and no change in ceramide, sphingomyelin, or acylcarnitine content. This was associated with an increase in phosphorylation of PKCα and PKCδ, and a decrease in phosphorylation of AKT and expression of CREB, PGC1α, PPARα and the mitochondrial fusion genes MFN1, MFN2 and OPA1. FATP1 overexpression also led to marked decreases in mitochondrial size (-49%, p<0.01), complex II-driven respiration (-28.6%, p<0.05), activity of isolated complex II (-62%, p=0.05), and expression of complex II subunit B (SDHB) (-60% and -31%, p<0.01) in the absence of change in ATP synthesis. Hydrogen peroxide production was not increased in FATP1 mitochondria, and cardiac hypertrophy and diastolic dysfunction were not attenuated by overexpression of catalase in mitochondria in FATP1 mice.

conclusionsExcessive delivery of FAs to the cardiac myocyte in the absence of systemic disorders leads to activation of lipid-driven signaling and remodeling of mitochondrial structure and function.

Indexed as

Adenosine TriphosphateAnimalsCarnitineCatalaseCeramidesCyclic AMP Response Element-Binding ProteinDiglyceridesElectron Transport Complex IIFatty Acid Transport ProteinsGene Expression RegulationHydrogen PeroxideLipidsMiceMitochondria, HeartModels, BiologicalMyocardiumacylcarnitineAdenosine TriphosphateCarnitineCatalaseCeramidesCyclic AMP Response Element-Binding ProteinDiglyceridesElectron Transport Complex IIFatty Acid Transport ProteinsHydrogen PeroxideLipidsPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPPAR alphaPpargc1a protein, mouseProtein Kinase CProto-Oncogene Proteins c-aktRNA, MessengerSlc27a1 protein, mouseSphingomyelinsTranscription FactorsLipid excessMetabolic heart diseaseMitochondriaObesity

Identifiers

PMID25497302
PMCPMC4301992
OpenAlexW2075210458

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.